Guggenheim analyst Louise Chen is out defending The Medicines Company (NASDAQ: MDCO) amid today's weakness following the company's 2Q15 miss ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE